Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.05 HKD | +1.15% | -4.34% | +5.50% |
May. 14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
May. 14 | Everest Medicines Announces Commercial Launch and First Prescription for NEFECON in Mainland China | CI |
Sales 2024 * | 677M 93.43M 730M | Sales 2025 * | 1.5B 207M 1.62B | Capitalization | 6.54B 903M 7.06B |
---|---|---|---|---|---|
Net income 2024 * | -646M -89.21M -698M | Net income 2025 * | -160M -22.1M -173M | EV / Sales 2024 * | 8.34 x |
Net cash position 2024 * | 901M 124M 972M | Net cash position 2025 * | 336M 46.4M 363M | EV / Sales 2025 * | 4.13 x |
P/E ratio 2024 * |
-10
x | P/E ratio 2025 * |
-40.6
x | Employees | 432 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.97% |
Latest transcript on Everest Medicines Limited
1 day | +1.15% | ||
1 week | -4.34% | ||
1 month | -9.82% | ||
3 months | -9.07% | ||
6 months | +9.98% | ||
Current year | +5.50% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Qing Luo
CEO | Chief Executive Officer | 54 | 22-09-18 |
Ian Ying Woo
PSD | President | 51 | 18-11-30 |
Michael Berry
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yi Fan Li
BRD | Director/Board Member | 55 | 20-08-31 |
Honggang Feng
BRD | Director/Board Member | 59 | Feb. 08 |
Wei Fu
CHM | Chairman | 42 | 17-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.75% | 4 M€ | -27.92% | ||
0.01% | 4 M€ | -4.41% | - | |
0.00% | 112 M€ | +4.61% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 22.05 | +1.15% | 3,118,500 |
24-05-30 | 21.8 | -1.36% | 2,426,500 |
24-05-29 | 22.1 | -2.64% | 4,270,000 |
24-05-28 | 22.7 | -.--% | 1,763,194 |
24-05-27 | 22.7 | -1.52% | 2,740,500 |
Delayed Quote Hong Kong S.E., May 31, 2024 at 04:08 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.50% | 903M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- 1952 Stock